Modulation of Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Gastrointestinal Cancers by Phytochemicals

Area of Science:

• Oncology
• Molecular Biology
• Pharmacology

Background:

• Gastrointestinal (GI) malignancies are significantly driven by abnormal activation of the mitogen-activated protein kinase (MAPK) signaling cascade.
• Standard cancer treatments often cause severe side effects, impacting patient quality of life.
• There is a growing need for safer, multitargeted therapeutic agents in cancer treatment.

Purpose of the Study:

• To review the role of phytochemicals in modulating the MAPK signaling pathway for GI cancer treatment.
• To explore the potential of phytochemicals as a complementary or alternative therapy for GI malignancies.
• To summarize current knowledge on phytochemicals targeting MAPK in GI cancers.

Main Methods:

• Literature review of studies investigating phytochemicals and their effects on the MAPK pathway in GI cancer models.
• Analysis of in vitro and in vivo data on phytochemicals' impact on cancer proliferation, apoptosis, invasion, angiogenesis, and metastasis.
• Examination of the mechanisms of action and limitations of phytochemicals in GI cancer therapy.

Main Results:

• Phytochemicals demonstrate the ability to inhibit tumor development and induce cancer cell death by selectively targeting components of the MAPK pathway.
• These compounds exhibit multifaceted signaling regulatory actions beneficial for tumor inhibition.
• Phytochemicals have shown potential in both in vitro and in vivo GI cancer models.

Conclusions:

• Phytochemicals represent a promising strategy for managing MAPK pathway dysregulation in gastrointestinal cancers.
• Further research is warranted to fully elucidate the therapeutic potential and optimize the use of phytochemicals.
• Phytochemicals offer a potentially safer and effective approach to GI cancer treatment.